Apps und webbasierte Interventionen in der Prostatakrebsnachsorge – ein Scoping Review

Pornak, Shirin Caroline; Papachrysanthou, A.; Lehr, Bosco

doi:10.1007/s00120-020-01440-1

Cited by 2 publications

(1 citation statement)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 12 33 34 There are some narrow or scoping reviews that have demonstrated the potential effectiveness and feasibility of web-based interventions. 35 36 Two systematic reviews and meta-analyses, each including ten studies, have assessed the effectiveness of web-based interventions. Their findings suggest that web-based interventions are effective in improving cancer-related stress, anxiety, depression and quality of life in prostate cancer survivors.…”

Section: Introductionmentioning

confidence: 99%

Effectiveness of web-based intervention on reducing symptom burden, improving self-management capabilities and self-efficacy among prostate cancer survivors: a systematic review and meta-analysis protocol

Li,

Zhu,

Wang

et al. 2024

BMJ Open

View full text Add to dashboard Cite

IntroductionProstate cancer is the most common malignant disease within the male genitourinary system. Advances in cancer screening and treatment have significantly ameliorated the survival rates of patients with prostate cancer. Nonetheless, prostate cancer survivors report various degrees of cancer-related symptoms. These symptoms cause physiological and psychological suffering, leading to a deterioration of quality of life. Web-based interventions may facilitate the management of symptoms due to their flexibility, accessibility and convenience. However, the efficacy of web-based interventions in reducing symptom burden remains to be confirmed. Consequently, this systematic review and meta-analysis aims to comprehensively synthesise existing evidence, evaluate the effectiveness of web-based interventions in reducing symptom burden among patients and furnish a reference for clinical practice.Methods and analysisThis protocol strictly adheres to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocol guidelines. We will comprehensively search six databases (PubMed, Web of Science, Cochrane, Embase, CINAHL and PsycINFO) from their inception to March 2024 in order to identify clinical trials on the efficacy of web-based interventions for prostate cancer survivors. Two reviewers will independently conduct study selection, data extraction and quality assessment. The risk bias of included studies will be assessed using the Cochrane Risk of Bias Tool for randomised trials 2.0, and the strength of evidence will be assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE) guideline. Meta-analysis will be performed using STATA V.16.0, and the effect size will be calculated using the standardised mean difference and its 95% CI. Heterogeneity will be assessed using Cochran’s Q statics and inconsistency will be measured using the I2statistics. Potential sources of bias will be evaluated.Ethics and disseminationEthics approval is not required for this review as no human participants will be involved. The results will be disseminated via a peer-reviewed journal or an academic conference.PROSPERO registration numberCRD42023457718.

show abstract

Section: Introductionmentioning

confidence: 99%